Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET)

NCT04720391 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT04720391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04720391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET)
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Unknown status
Start date
January 8, 2021
Completion date
December 31, 2021
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, neuroendocrine neoplasm